C2N Diagnostics is a company that develops and commercializes diagnostics for Alzheimer’s disease and related forms of neurodegeneration. It offers Precivity tests, blood tests that help healthcare providers determine the presence or absence of amyloid plaques in the brain. The company also provides blood biomarker screening and monitoring tools for Alzheimer’s and other related dementia clinical studies.